OncoCyte Corporation (OCX)

USD 2.2

(-0.45%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 74.89 Million 100.09 Million 159.56 Million 55.41 Million 39.85 Million 9.51 Million
Total Current Assets 10.69 Million 25.53 Million 39.14 Million 9.22 Million 22.95 Million 8.64 Million
Cash And Short Term Investments 9.43 Million 20.42 Million 36.5 Million 7.81 Million 22.45 Million 8.46 Million
Cash and Cash Equivalents 9.43 Million 19.99 Million 35.6 Million 7.14 Million 22.07 Million 8.03 Million
Short Term Investments - 433 Thousand 904 Thousand 675 Thousand 379 Thousand 428 Thousand
Net Receivables 484 Thousand 2.01 Million 1.43 Million 203 Thousand - -
Inventory - 2.12 Million 304 Thousand - - -
Other Current Assets 782 Thousand 977 Thousand 1.19 Million 1.2 Million 505 Thousand 180 Thousand
Total Non-Current Assets 64.19 Million 74.55 Million 120.42 Million 46.19 Million 16.9 Million 876 Thousand
Net PPE 5.43 Million 10.85 Million 8.52 Million 6.52 Million 3.72 Million 614 Thousand
Good Will And Intangible Assets 56.59 Million 61.63 Million 109.92 Million 24.19 Million - -
Good Will - - 18.68 Million 9.18 Million - -
Intangible Assets 56.59 Million 61.63 Million 91.24 Million 15 Million - -
Long-Term Investments 1.7 Million 1.7 Million 1.7 Million 13.41 Million 10.96 Million -
Tax Assets -1.00 -1.7 Million -1.7 Million 118 Thousand - -
Other Non Current Assets 463 Thousand 2.07 Million 1.96 Million 1.93 Million 2.21 Million 262 Thousand
Other Assets 1.00 - - - - -
Total Liabilities 49.29 Million 65.79 Million 94.34 Million 21.93 Million 9.02 Million 6.09 Million
Total Current Liabilities 7.19 Million 12.1 Million 14.12 Million 8.99 Million 4.44 Million 5.56 Million
Account Payables 953 Thousand 1.25 Million 2.44 Million 432 Thousand 469 Thousand 166 Thousand
Tax Payables - - - - - -
Short Term Debt 665 Thousand 815 Thousand 2.13 Million 2.81 Million 1.35 Million 1.18 Million
Deferred Revenue - - - 5.15 Million - -
Other Current Liabilities 5.57 Million 10.03 Million 9.54 Million 600 Thousand 2.61 Million 4.21 Million
Total Non Current Liabilities 42.1 Million 53.69 Million 80.22 Million 12.94 Million 4.58 Million 534 Thousand
Long-Term Debt 2.2 Million 2.72 Million 3.54 Million 5.82 Million 4.58 Million 534 Thousand
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 39.9 Million 50.96 Million 76.68 Million 7.12 Million - -
Other Liabilities - - - - - -
Total Equity 25.59 Million 34.29 Million 65.21 Million 33.48 Million 30.83 Million 3.42 Million
Stock Holders Equity 25.59 Million 34.29 Million 65.21 Million 33.48 Million 30.83 Million 3.42 Million
Common Stock 310.29 Million 294.92 Million 252.95 Million 157.16 Million 124.58 Million 74.74 Million
Retained Earnings -289.87 Million -260.67 Million -187.77 Million -123.67 Million -93.74 Million -71.31 Million
Accumulated other comprehensive income 49 Thousand 39 Thousand 37 Thousand - - -
Common Stock Equity 25.59 Million 34.29 Million 65.21 Million 33.48 Million 30.83 Million 3.42 Million
Capital Lease Obligation 2.86 Million 3.54 Million 4.36 Million 4.73 Million 2.9 Million 572 Thousand
Total Investments 1.7 Million 433 Thousand 904 Thousand 14.09 Million 11.34 Million 428 Thousand
Total Debt 2.86 Million 3.54 Million 5.67 Million 8.63 Million 5.93 Million 1.71 Million
Net Debt -6.56 Million -16.44 Million -29.92 Million 1.48 Million -16.13 Million -6.31 Million

Balance Sheet Charts